Department of Pediatrics, Children's Mercy Hospitals & Clinics, 2401 Gillham Road, Kansas City, MO 64108, USA.
Genomics. 2010 Nov;96(5):303-7. doi: 10.1016/j.ygeno.2010.07.009. Epub 2010 Aug 5.
KLF1 regulates definitive erythropoiesis of red blood cells by facilitating transcription through high affinity binding to CACCC elements within its erythroid specific target genes including those encoding erythrocyte membrane skeleton (EMS) proteins. Deficiencies of EMS proteins in humans lead to the hemolytic anemia Hereditary Spherocytosis (HS) which includes a subpopulation with no known genetic defect. Here we report that a mutation, E339D, in the second zinc finger domain of KLF1 is responsible for HS in the mouse model Nan. The causative nature of this mutation was verified with an allelic test cross between Nan/+ and heterozygous Klf1(+/-) knockout mice. Homology modeling predicted Nan KLF1 binds CACCC elements more tightly, suggesting that Nan KLF1 is a competitive inhibitor of wild-type KLF1. This is the first association of a KLF1 mutation with a disease state in adult mammals and also presents the possibility of being another causative gene for HS in humans.
KLF1 通过与 CACCC 元件高亲和力结合,促进其红细胞特异性靶基因(包括编码红细胞膜骨架 [EMS] 蛋白的基因)的转录,从而调节红细胞的定型。人类 EMS 蛋白的缺乏导致溶血性贫血遗传性球形红细胞增多症(HS),其中包括一部分没有已知遗传缺陷的亚群。在这里,我们报告 KLF1 的第二个锌指结构域中的 E339D 突变是导致 Nan 小鼠模型中 HS 的原因。Nan/+ 和杂合性 Klf1(+/-) 敲除小鼠之间的等位基因测试交叉验证了这种突变的因果关系。同源建模预测 Nan KLF1 与 CACCC 元件结合更紧密,表明 Nan KLF1 是野生型 KLF1 的竞争性抑制剂。这是 KLF1 突变与成年哺乳动物疾病状态的首次关联,也为人类 HS 的另一个致病基因提供了可能性。